Abstract: The choroid plexuses are involved in CSF secretion and CSF K homeostasis. This study examines the potential role of K cotransport in these two processes using isolated rat lateral ventricle choroid plexuses . Bumetanide-sensitive 86 Rb influx and efflux were measured to assess the response of K cotransport to changes in media osmolality and K concentration . Alterations in osmolality had no effect on K uptake (in the presence or absence of Bumetanide) . However, the efflux rate constant for K was 0.29 -0.02, 0.44 --0.04, and 0.84 -0.06 min ' in 240, 300, and 424 mOsm/kg solutions, respectively (p < 0.001) . This increase in efflux with osmolality,
1994 ; Keep et al ., 1994) . Bumetanide-sensitive cotransport comprises -V45% of K uptake and 80% of K efflux in isolated rat choroid plexuses . Both inward and outward cotransport are probably of the Na/K/20 form and may indeed be the same transporter operating in both directions .
Despite the predominance of cotransport in K movement at the choroid plexus, the function of this transport is uncertain. In view of the importance of the choroid plexus in CSF K regulation and the known role of Na/K/20 cotransport in cell volume regulation in other +issues, we have examined the potential modulation of cotransport by [K] and osmolality in the isolated rat choroid plexus .
MATERIALS AND METHODS
Experiments were performed on lateral ventricle choroid plexuses isolated from pentobarbital (50 mg/kg)-anesthetized Sprague-Dawley rats aged between 30 and 50 days . For each data point, a rat was decapitated, the plexuses dissected, weighed (influx studies only), and transferred to control buffer at 37°C . There was a 5-min recovery period before the beginning of any experiment . Measurements on the rate of K uptake and efflux in choroid plexuses were then made with "Rb rather than ''K because of its longer half-life. The rate of movement of these two ions by many transport systems, including the choroid plexus K cotransporter , is similar.
Rubidium influx and efflux
These methods are presented in detail in Keep et al . ( 1994) . In brief, for "Rb uptake, measurements were made over 30 s using ['HJmannitol (osmolality experiments) or [3H]dextran (K experiments) to correct for isotope in the extracellular space. Uptake was terminated by transferring the plexus to iced control buffer and filtering under reduced pressure . The filters were washed three times with the same buffer . The filters and choroid plexuses were then soaked in 1 M hyamine hydroxide (a tissue solubilizer) before the addition of' scintillation cocktail (Cytoscint) and counting with a dual-channel liquid scintillation counter ( Beckman LS 3801 ; Fullerton, CA, U.S .A .) .
The rate of uptake of "Rb into choroid plexus, in microliters per milligram per minute, was corrected for extracellular space. Then, assuming that "'Rb is transported into the choroid plexus at the same rate as K, the rate of uptake of K (nanomoles per milligram per minute) was calculated by multiplying by the K concentration of the external medium .
For efflux measurements, plexuses were allowed to accumulate`Rb for 10 min, washed in control buffer for 15 s, and then transferred to efflux buffer . After a 30-s preincubation period, the efflux buffer was sampled at 30-s intervals for 2 min. Hyamine hydroxide ( I M) was then added to the final solution plus choroid plexus . This solution was then heated at 70°C, sampled, and the final choroid plexus isotope contents were determined after addition of scintillation cocktail .
For each experiment, the fraction of the initial choroid plexus`Rb content, corrected for extracellular space, was calculated for each time point (0, 0.5, I, 1 .5, and 2 min) . The natural logarithms of these values were plotted against time and the slope determined by linear regression analysis . The slopes of these plots equal the efflux rate constants (K ) with units of min ' .
Experimental protocol : effect of osmolality
For experiments examining the effects of osmolality on K transport, plexuses were exposed to the media of different osmolalities for 10 min before and during the measurement of the rate of "Rb uptake or efflux . For efflux studies, this exposure was during the "'Rb-uptake phase of the experiment . Bumetanide (30 NM) and ouabain (5 mM) were used to inhibit cotransport or Na,K-ATPase activity, respectively . These drugs were present for 30 s before the onset of and during the uptake or efflux measurement.
Experimental protocol : effect of external [K] To examine the effect of exposure to media of different K concentrations on the rate of K efflux, plexuses were exposed to 1, 2.9, or 6 mM K for I h. The rate of efflux was then measured either in those solutions or 30 s after return to control CSF (2 .9 mM K) . Parmelee et al . ( 1991 ) have already shown that K uptake into rat choroid plexus shows saturation kinetics . The purpose of the uptake experiments undertaken in this study, however, was to determine whether K uptake is altered by exposure to different K concentrations other than by an effect due to affinity of K for the transporters ; i .e., whether there is regulation of either the number or the activity of the cotransporters . To this purpose, two sets of experiments were designed . In the first set of experiments, plexuses were exposed to dillerent I K I (for periods up to 1 h) but were transferred back to conrol ( K I media for 30 s ( unless stated ) for the measurement of "6Rh uptake. In the second set, the rate of uptake was compared in choroid plexuses exposed to 1 mM K for either 0.5 or 60 min and measurements of uptake were made in this media. Thus, in both sets of experiments, comparisons of uptake were made in media with the same [K] .
As there was the possibility that choroid plexus K transport might change with the length of time after isolation, statistical comparisons were limited to plexuses isolated for l . Nruroc'hcrn ., Vol . 64, No. 6, /995 R. P. KEEP AND J. XIANC FIG. 1 . The effect of 10-min exposure to media of different osmolalities on the rate of K ("Rb) influx into rat lateral ventricle choroid plexus . Measurements were made in the presence or absence of 30 pM bumetanide, which was added 30 s before the uptake measurement. All values are means -SE ; n -5-12 . The bumetanide-sensitive flux was calculated by subtracting the flux in the presence of bumetanide from the total (control) flux . the same period of time . Where necessary, this was ensured by preincubating plexuses in control buffers for longer periods of time . As there was also the possibility of cell mortality either in response to the isolation or due to the exposure to different media, the release of a cytostolic enzyme, lactate dehydrogenase, into the external medium was used as a measure of membrane integrity. Lactate dehydrogenase concentrations were measured using a commercially available diagnostic kit (Sigma, St . Louis, MO, U.S .A .) . This measures the lactate dehydrogenase-dependent conversion of pyruvic acid + NADH to lactic acid + NAD by determining pyruvic acid concentrations colorimetrically after reaction with 2,4-dinitrophenylhydrazine . Lactate dehydrogenase release was compared with total tissue concentrations obtained after disruption with an IKA-Ultra-Turrax T25 homogenizer (IKA, Cincinnati, OH, U.S .A .) .
Buffers
Bicarbonate buffers were continuously bubbled with 5% C0,/95% O-and contained 127 mM NaCl, 20 mM NaHCO,, 2 .4 mM KCI, 0.5 rnM KH,PO,, 1 .1 mM CaCl-, 0.85 in M MgCl,, 0.5 mM Na=S0,, and 5 inM glucose (pH 7 .4) . Changes in [K] were achieved by substituting NaCl for KCI. Changes in osmolality were obtained by altering the concentration of NaCl . 
Statistics
All comparisons were made using analysis of variance with a Newman-Keuls multiple comparisons test . Differences were considered significant at the P < 0.05 level (twotailed) . Data presented in the text are given as mean ± SE Values .
RESULTS

Osmolality and cotransport
Changes in osmolality did not alter the rate of "'Rb uptake significantly (either in the absence or presence of bumetanide; Fig. 1 ) . However, the efflux rate con- stant for 86Rb rose progressively as buffer osmolality was increased by manipulation of [NaC]] (Fig . 2 ) . This increase in efflux rate was wholly explained by an enhancement of the bumetanide-sensitive portion of the efflux . At osmolalities > 240 mOsm/kg, there was an approximately linear relationship between the bumetanide-sensitive efflux rate and buffer osmolality (Fig . 2 ) . An extrapolation of this relationship suggests the efflux cotransporter is inactivated at osmolalities < 190 mOsm/kg . Efflux in the presence of bumetanide did not increase with osmolality . In fact, it was elevated at low osmolalities .
Extracellular [K] and cotransport Alterations in the [K] of the external media had a pronounced effect on choroid plexus K uptake (Fig .  3 ) . In these experiments, choroid plexuses were exposed to different K concentrations for 1 h before being FIG . 3 . The effect of 1-h exposure to media of different K concentrations on the rate of K ( 86Rb) uptake on return to control CSF (2 .9 mM K) . All values are means --SE ; n = 5-11 ; ,p < 0 .05, . .p < 0 .01, " . .p < 0 .001, significant differences from control (2 .9 mM K) .
CHOROID PLEXUS POTASSIUM COTRANSPORT 2749 FIG . 4 . The effect of different durations of exposure to 1 or 2 .9 mM K artificial CSF on the rate of K influx in choroid plexuses 30 s after transfer to control (2 .9 mM K) CSF . Also shown is the effect on K uptake of 30-min exposure to 1 mM K followed by 30 min in 2 .9 mM K . All values are means ± SE ; n = 5-12 ; .p < 0 .05,`. .p < 0 .001, significant differences from control measurements at the same time point ; tp < 0 .05, significant difference from plexuses exposed to 1 mM K .
transferred back into control media (2 .9 mM K) for "Rb uptake measurements . The rate of K uptake progressively declined as the choroid plexuses were exposed to lower K concentrations, with 1 mM K inducing a 64% reduction (p < 0.001 ; Fig . 3 ) . There was also a slight, but significant (p < 0.05), decrease in K uptake in plexuses exposed to a high [ K ] media (6 mM) . The time course of the effect of low [ K ] (1 m M ) on K uptake was examined with all measurements being made on return to control buffer . After 10-min exposure there was no significant effect on the rate of uptake compared with a time-matched control (Fig .  4) . By 30 min, however, uptake was suppressed and this effect was even greater at 60 min. The reversibility of this process was examined using plexuses exposed to 1 mM K for 30 min before being transferred back to control buffer for 30 min . This procedure did not return the uptake to control values, but it did prevent the further decline in uptake that occurred during 60-min exposure to 1 mM K (Fig . 4) .
The mechanism for the reduction in K uptake in 1 mM K was examined in two sets of experiments . In the first, K uptake was measured in plexuses exposed to 60 min of I or 2 .9 mM K followed by 30 s in control (2 .9 mM K) CSF with or without ouabain or bumetanide before the measurement of K ( K6 Rb) uptake . In plexuses exposed to 2 .9 mM K for I h, ouabain and bumetanide (p < 0.001 ) reduced the K uptake by -53 and -33%, respectively . In plexuses exposed to I mM K, the ouabain-insensitive flux was reduced from 8 .1 -~0.5 to 1 .2 + 0.7 nmol/mg/min (p < 0.001) and there was no longer a significant reduction in uptake in the presence of bumetanide (Fig . 5A ) .
In the second procedure, the reverse experiment was performed. Plexuses were exposed to 60 min of 1 or 2 .9 mM K followed by 30 s in 1 mM K CSF with or without ouabain or bumetanide before the measurement of K uptake . In these experiments, total K influx FIG . 5 . Effect of exposure to 1 mM K on choroid plexus K uptake measured in the presence or absence of ouabain (5 mM) or bumetanide (30 pM) . A : K ("Rb) uptake in plexuses exposed to either control (2 .9 mM K) or 1 mM K artificial CSF for 1 h . Uptake measurements were made 30 s after transfer to fresh 2 .9 mM CSF . B: K uptake in plexuses exposed to 1 mM K for 0 .5 or 60 min . Values are means ± SE ; n = 5-9 ;
.`p < 0 .01 and .**p < 0 .001, compared with respective controls with the same duration of exposure to 1 mM K ; tp < 0 .05, ttp < 0 .01, compared with same condition in plexuses exposed to 1 mM K for 0 .5 min .
rate was reduced from 6.0 ± 0 .5 nmol/mg/min in plexuses exposed to 1 mM K for 30 s to 3.6 ± 0.4 nmol/ mg/min in plexuses exposed for 1 h (P < 0.01 ; Fig .  5B ) . This was due to a reduction in the ouabain-insensitive flux from (3 .6 -+ 0.3 to 1 .1 ± 0.1 nmol/mg/min ; p < 0.05) . Again, plexuses with prolonged exposure to 1 mM K had no significant reduction in K uptake in the presence of bumetanide (Fig . 5B) . One difference in the results between the two procedures, measurements in 2 .9 and 1 mM K, was that in the former, prolonged exposure to I mM K also produced a slight reduction in the uptake measured in the presence of bumetanide (i.e ., bumetanide-insensitive ; Fig . 5A ) . When determinations were made in 1 mM K, however, there was no reduction in bumetanideinsensitive uptake after 1-h exposure compared with measurements after 30 s (Fig . 5B) .
Altering external medium [K] to 1 or 6 mM had no significant effect on the efflux rate constant for K ( 86 Rb) at the choroid plexus (Table 1) . This was the case whether the measurements were made in the presence of the altered [K] or after the return of the plexus to control buffer for 30 s before the efflux determination . Choroid plexuses exposed to 6 mM K did, however, have a slightly greater bumetanide-insensitive ef-J. Neurochem. . Vol . 64, No . 6, 1995 R. F. KEEP AND J. XIANG flux rate constant compared to controls whether the measurement was made at 6 mM K (p < 0.01) or after return to 2 .9 mM K media (p < 0.05) .
To examine whether the alterations in choroid plexus K transport in response to changes in [K J might result from reduced membrane integrity, lactate dehydrogenase release was measured . The percentage of total choroid plexus lactate dehydrogenase released during 1 h of incubation in 1, 2, 2.9, and 6 mM K was 10 .2±0 .9, 11 .0-0 .5,6 .1 ±0.4,and 10 .4---2 .8%, respectively (n = 4-5) . These values were not significantly different .
DISCUSSION
The choroid plexus epithelium has a high density of Na/K pumps, -3 million/cell (Wright, 1978 ) . Yet, K uptake by bumetanide-sensitive cotransport is approximately equal to that via the Na/K pump and the rate of bumetanide-sensitive K efflux is probably greater than either . Despite its quantitative magnitude, the function of K cotransport at the choroid plexus is uncertain . The results presented in this study suggest that K cotransport may play a role in both volume and K regulation in the CNS . However, it appears that whereas volume regulation may involve alterations in outward cotransport, K regulation may involve the inward component. Although others have shown that imposing ion gradients can drive K cotransport in both directions in other cell types (e .g., Gargus and Slayman, 1980; Altamirano and Russell, 1987) , we are unaware of another cell type where both directions appear to be separately regulated and have separate physiological functions .
Cotransporter : type and location
The interpretation of the physiological importance of the results obtained in this study depends upon the location of the K cotransporter or cotransporters, whether the inward and outward K transport are via the same mechanism, and whether that mechanism is of the KCI or Na/K/Cl form. Much of the evidence for our belief that there is an apically situated Na/K/ 20 cotransporter that moves K into and out of the choroid plexus epithelial cells is outlined in . In brief, bumetanide, an inhibitor of either Na/K/Cl or KCI cotransport, reduces K, Na, and Cl influx into isolated rat choroid plexus Bairamian et al ., 1991 ; Keep et al ., 1994) , the bumetanide-sensitive portion of K ("Rb) influx is absent if external Na is removed , and the bumetanide-sensitive influx of Na, K, and Cl are in the ratio of approximately 1 :1 :2 Keep et al., 1994) as expected from an Na/ K/2C1 cotransporter found in many tissues . In a similar manner, in the rat, there is bumetanide-sensitive K, Na, and Cl efflux (Preston et al ., 1993 ; Keep et al ., 1994) ; R(+)-butylindazone, an inhibitor of KCI cotransport, had no effect on K efflux ), but increasing intracellular or extracellular Na enhanced the bumetanide-sensitive efflux . In total, this suggests the K cotransport efflux mechanism is of the Na/K/Cl form, and we have postulated that it is the same as the inward transporter operating in both directions . In contrast to other tissues, efflux through the cotransporter is greater than influx in the rat choroid plexus . This probably is due to a very high density of Cl/HCO3 exchangers in this tissue (Lindsey et al ., 1990 ) that results in a relatively high intracellular chloride concentration (Smith and Johanson, 1985) compared with other tissues and an electrochemical gradient favoring efflux through the transporter .
As to the location of a cotransporter, Zeuthen (1991a,b) has provided substantial evidence that there is an apically located efflux K cotransporter in Necturus choroid plexus . In the isolated rat choroid plexus, K cotransport and Na,K-ATPase are the main K influx mechanisms . The rate of K efflux through the cotransporter is greater than either uptake mechanism alone ; thus, if only the Na,K-ATPase were located on the apical membrane, there would be a substantial net efflux of K across the apical membrane and a K-rich CSF. This is not the case, suggesting that the influx cotransporter is also apically located and may be the efflux cotransporter operating in both directions . The experiments presented in this study do not directly provide evidence as to the location of the cotransporter . However, we believe that if the osmotic and ionic effects described were on an apically located cotransporter, they would best agree with previously reported in vivo data on brain ion and fluid balance regulation (see below) .
Cotransport and volume regulation
Many cell types modulate K transport as a volumeregulatory mechanism . This involves an increased uptake via K cotransport during hyperosmotic stress to limit cell shrinkage and an increase in K efflux during CHOROID PLEXUS POTASSIUM COTRANSPORT Efflux rate constant (min -') Efflux rate constant for K ("°Rb) in the absence or presence of bumetanide (30 PM) measured after a 1-h exposure to CSF with different K concentrations . Measurements were either made in these media or after 30-s exposure to fresh control (2 .9 nuV! K) CSF. Values are means -SE ; n = 5 . "p < 0.01 and 'p < 0.05, values significantly different from the control (2 .9 mM K) + bumetanide. 2751 hypoosmotic stress to limit cell swelling (Geck and Heinz, 1986) . The latter may in some cells involve the activation of K cotransport (Garay et al ., 1988) . In contrast, the choroid plexus shows the opposite effect, an increase in outward K cotransport with increasing osmolality . This study in a mammalian species complements that of Zeuthen (1991 b) in an amphibian, Necturus, who also found an increase in K cotransport efflux in response to hyperosmotic stress . The reason for this difference may lie in the role of the choroid plexus as a barrier tissue . Thus, whereas other cells increase ion influx during hyperosmotic stress to maintain cell volume, the choroid plexus may increase efflux via the cotransporter to move solutes into the brain and, thus, help to maintain brain volume.
Thus, although plasma hyperosmolality causes a loss of water from the brain, this loss is less than expected from a tissue that does not volume regulate due to a net gain in brain solutes that limits the water loss necessary for osmotic equilibrium between blood and brain (reviewed in Cserr and Patlak, 1991) . At least during short-term changes in osmolality, Na, Cl, and K appear to be the main solutes gained during hyperosmotic stress (e .g ., Cserr et al ., 1987a ; Keep et al ., 1993b) . Such solutes must traverse the blood-brain or blood-CSF barrier to move from blood to brain . If the Kcotransport efflux pathway is an Na/K/2C1 cotransporter situated on the apical membrane of the choroid plexus, as we have hypothesized , an increase in efflux from the choroid plexus epithelium through this mechanism could participate in the net uptake of these ions during hyperosmotic stress . It is interesting that hyperosmotic stress results in an increase in CSF [K] (Bradbury and Kleeman, 1969) and an increase in the rate of blood to CSF K (86Rb) transport (unpublished observation) that might result from stimulation of a choroid plexus K-cotransport pathway if it were present on the apical membrane .
The results presented in this study enable an estimate of the importance of the choroid plexus cotransporter in brain volume regulation during hyperosmotic stress J. Neurochern ., Vol. 64, No . 6, 1995 Johanson and Murphy (1990) assuming 3 mg of plexus/g brain], this would increase the efflux of K into the CSF by -3 p,mol/g/h . This compares with measured increases in brain K content of -10 /-tmol/g during an hour of a similar osmotic stress in vivo (Keep et al., 1993b) . The remaining uptake might be due to changes in blood-brain barrier ion transport . Cserr et al. (1987b) have reported an increase in blood-brain barrier K transport in response to hyperosmotic stress . Whether K cotransport is involved in blood-brain barrier K transport is a matter of controversy (Keep et al., 1993a) . Alterations in K cotransport may serve to limit brain volume changes during osmotic stress other than by limiting the osmotic shifts of water necessary to maintain isosmolality between blood and brain. Zeuthen (1991a,b) has shown in the amphibian choroid plexus that K cotransport is intimately linked to fluid secretion. In mammalian species, intracerebroventricular infusion of bumetanide can also reduce CSF secretion rate (Johnson et al., 1987 ; Javaheri and Wagner, 1993) . This suggests that changes in osmolality, by affecting K-transport activity, may alter CSF secretion rate.
Indeed, Wald et al . (1976) found that there was a positive linear relation between CSF osmolality and CSF bulk flow in the cat. The slope of this relation was decreased by -60% in the presence of acetazolamide, an inhibitor of carbonic anhydrase, suggesting an involvement of active secretion. It is interesting that Wald et al. (1976) also found no effect of acetazolamide on CSF flow at a CSF osmolality of 190 mOsm/ kg. This is in very close agreement to the osmotic sensitivity of the K cotransporter presented here. It was also abolished at osmolalities below -190 mOsm/kg . Acetazolamide may act indirectly to diminish K-efflux cotransport by altering the electrochemical gradients for Na and Cl via an inhibition of basolateral Na/H and Cl/HC03 exchange. We have found thatprolonged exposure to an inhibitor of Cl/HCO3 exchange, 4-4'-diisothiocyanatostilbene-2,2'-disulfonic acid, also inhibits K-efflux cotransport (unpublished observations) .
This study does not examine directly how hyperosmotic stress increases efflux K cotransport . Whether these changes are due purely to changes in the electrochemical gradients for K, Na, and Cl or whether cotransport is regulated by other factors is uncertain . In vivo, the choroid plexus has many neuroendocrine inputs (Nilsson et al., 1992) and some of these, particularly those postulated to be involved in brain volume regulation, might also regulate this cotransporter.
Unlike the efflux via the K cotransporter, bumeta-J. Neu r o, hem., Vol. 64, No . 6, 1 995 R. F. KEEP AND J. XIANG nide-insensitive flux was increased in low osmolalities . This may reflect an opening of a K channel as part of epithelial cell volume regulation. Christensen (1987 ) has described a stretch-activated nonselective cation channel in choroid plexus .
Cotransport and K regulation In contrast to the osmotic effects described above, reductions in extracellular K concentration affected bumetanide-sensitive uptake and not efflux. Before discussing the possible physiological importance of this finding, it is important to assess whether this is a direct effect on transport or whether it might be explained by a decreased viability of the tissue in 1 mM K. The following four observations suggest that the latter is not the case : (1) 1 mM K appears to selectively reduce the bumetanide-sensitive portion of the flux (Fig. 5B ) but (2) has no effect on the efflux rate constant. (3) We examined whether a recovery period in control CSF would alter the`Rb uptake. Thirty minutes of exposure to 2.9 mM K after 30 min in 1 mM K did not result in a return of the rate of uptake to a control value . It did, however, prevent the further decline in uptake that occurred by 60 min of l mM K exposure . (4) Finally, cell viability, as measured with lactate dehydrogenase, was not significantly affected by a 1-h exposure to media with K concentrations varying from 1 to 6 mM . If the reduction in K uptake found in l mM K were due solely to cell lysis, a 65% release of lactate dehydrogenase would have been expected.
Alterations in external [ K I can affect K transport at the choroid plexus because of the affinity of K for the transporters and, therefore, all comparisons made in this study were between measurements made in buffers with the same [ K ] . In particular, comparisons were made of measurements after transfer of choroid plexuses back to 2.9 mM K or during different durations of exposure to 1 mM K. In both protocols, we found the bumetanide-sensitive portion of uptake to be abolished in choroid plexuses given prolonged exposure to 1 mM K. The only qualitative difference in the results between the two protocols was that uptake measured in the presence of bumetanide was also slightly reduced in plexuses returned to 2 .9 mM K from a 1-h exposure to 1 mM K, whereas there was no effect on this parameter in plexuses maintained in 1 mM K for 1 h compared with those exposed for 30 s. The reason for this difference is uncertain .
We have suggested that the influx of K via the cotransporter occurs at the apical membrane of the choroid plexus epithelium . If this is the case, the abolition of inward K cotransport in response to I mM K may be a CSF K homeostatic mechanism, because it would inhibit the removal of K from the CSF when CSF [K] is low . It is known in vivo that the [K] of newly formed CSF varies inversely with the K concentration of the CSF bathing the choroid plexus (Hunted and Reed, 1976) .
The reduction in K transport in response to low K was progressive over the course of 1 h . Thus, it is unlikely that this mechanism is involved in minute-tominute regulation of CSF [K] . Parmelee et al. ( 1991) have shown that K uptake by isolated choroid plexuses shows saturation kinetics with a K,,, of between 3 and 6 mM K close to the normal CSF [K] of 2.9 mM. This suggests that increases in CSF [K] will enhance directly K efflux from the CSF and contribute to CSF K homeostasis . In contrast, synaptosomal Na,KATPase has a K, of 0.47 mM, suggesting that it is saturated at normal physiological concentrations (Schielke et al., 1990) . Other than transporters, K channels may also play a role in CSF K homeostasis . The enhanced K efflux through a bumetanide-insensitive mechanism in response to 6 mM K might reflect an opening of a K channel . Whole-cell patch-clamp studies on rat choroid plexus epithelial cells have found a K channel that is activated by cell depolarization (Kotera and Brown, 1994) . Whether this channel is apically or basolaterally situated is unknown .
How the rate of K-cotransport efflux is altered by the reduction in extracellular [K] has still to be elucidated. The apical membrane of the epithelium is much more K permeable than the basolateral membrane (Zeuthen and Wright, 1981) and may respond to changes in external K in a manner similar to a K electrode . It is possible, therefore, that K transport is altered in response to the potential across this membrane either via a direct effect on the transport protein or as an indirect effect due to the release of a second messenger . Whether the alteration in K cotransport is due to a change in the number or the activity of individual transporters is also unknown, although the cloning of the Na/K/2C1 cotransporter should facilitate such studies .
Conclusion
The results presented suggest that choroid plexus cotransport plays an important role in both brain volume regulation and CSF [K] homeostasis . A greater knowledge of choroid plexus cotransports function and control might lead to a better understanding and treatment of diseases associated with increases in brain volume, such as ischemia and hydrocephalus . It may also help in our understanding of mineralocorticoid hypertension, as a recent study has suggested that the development of such hypertension is linked to an alteration in CSF K homeostasis (Klarr et al., 1995) .
